Hemas Holdings
Colombo healthcare and personal care conglomerate with regional pharma distribution.
Hemas Holdings is a Sri Lankan conglomerate with healthcare and consumer goods divisions. Founded in 1948, its FMCG arm produces personal care products (Baby Cheramy, Clogard) and its healthcare arm distributes pharmaceuticals across South and Southeast Asia.
- Type
- brand seeking distribution
- Location
- Colombo, Sri Lanka
- Founded
- 1948
- Website
- hemas.com
- Categories
- Medical & Healthcare Supplies, Personal Care
- Markets
- Bangladesh, Pakistan, Malaysia, United Arab Emirates
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- domain-registered (green), checked 2026-08-08 Domain registry record
- lei-lapsed (amber), checked 2026-08-30 GLEIF global LEI register (golden copy)
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
Import rules for these goods
- Cosmetic products must be notified in the EU Cosmetic Products Notification Portal (CPNP) before being placed on the EU market. European Commission (CPNP)
- For the US market, MoCRA requires cosmetic facility registration and product listing with the FDA. US FDA (MoCRA)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)